B. Maat

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

A. Karim, B. Maat, R. Hatlevoll, 1996, International journal of radiation oncology, biology, physics.

Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.

H. Bartelink, O. Dalesio, B. Maat, 1992, The New England journal of medicine.

Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups.

O. Dalesio, B. Maat, P. van Houtte, 1994, Lung cancer.

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups.

H. Bartelink, O. Dalesio, B. Maat, 1990, International journal of radiation oncology, biology, physics.

Radiotherapy for cancer of the lip. A long-term evaluation of 85 treated cases.

J. Roodenburg, B. Maat, J. Roukema, 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Radiotherapy Combined with Daily or Weekly cis-Diammine Dichloroplatinum (II) in Inoperable Non-Metastasized Non-Small Cell Lung Cancer: A Toxicity Report of the Randomized Phase III Study of the EORTC Lung Cancer Cooperative and Radiotherapy Cooperative Groups

H. Bartelink, O. Dalesio, B. Maat, 1991 .

DISSEMINATION OF TUMOUR CELLS VIA LEVEEN SHUNT

B. Maat, F. Lammes, H. White, 1979, The Lancet.

Intracranial cavernous angiomas: diagnosis and therapy.

B. Maat, C. Tijssen, A. A. op de Coul, 1989, European neurology.

Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups

H. Bartelink, O. Dalesio, B. Maat, 1993 .

Angiosarcoma of the irradiated breast: a new problem after breast conserving therapy?

B. Maat, L. Leenen, M. C. Kuizinga, 1991, The Netherlands journal of surgery.

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

L Collette, A Fourquet, E Van Limbergen, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Erlotinib as a Successful Treatment of Vision-Threatening Ocular Metastases from Non-Small-Cell Lung Cancer

B. Maat, G. Luyten, I. Birker, 2018 .